TY  - GEN
AU  - Kass,David A
TI  - Cardiac role of cyclic-GMP hydrolyzing phosphodiesterase type 5: from experimental models to clinical trials
SN  - 1546-9549
PY  - 2012///1227
KW  - Carbolines
KW  - therapeutic use
KW  - Cardiomyopathy, Dilated
KW  - drug therapy
KW  - Cyclic AMP
KW  - metabolism
KW  - Cyclic GMP
KW  - Cyclic GMP-Dependent Protein Kinases
KW  - drug effects
KW  - Cyclic Nucleotide Phosphodiesterases, Type 5
KW  - Fibrosis
KW  - Heart
KW  - Heart Failure
KW  - Humans
KW  - Hypertrophy
KW  - Myocardium
KW  - Phosphodiesterase 5 Inhibitors
KW  - Phosphoric Diester Hydrolases
KW  - Piperazines
KW  - Purines
KW  - Sildenafil Citrate
KW  - Sulfones
KW  - TRPC Cation Channels
KW  - Tadalafil
KW  - Transforming Growth Factor beta
KW  - Ventricular Remodeling
KW  - physiology
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
UR  - https://doi.org/10.1007/s11897-012-0101-0
ER  -